Improvement in progression-free survival in OCEANS bevacizumab arm: a critical point of view

J Clin Oncol. 2013 Jan 1;31(1):166-7. doi: 10.1200/JCO.2012.44.6237. Epub 2012 Nov 19.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Antineoplastic Agents / administration & dosage*
  • Fallopian Tube Neoplasms / drug therapy*
  • Female
  • Humans
  • Neoplasms, Glandular and Epithelial / drug therapy*
  • Ovarian Neoplasms / drug therapy*
  • Peritoneal Neoplasms / drug therapy*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents